COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches

S Kakavandi, B Hajikhani, P Azizi, F Aziziyan… - Cell Communication and …, 2024 - Springer
Extensive research in countries with high sociodemographic indices (SDIs) to date has
shown that coronavirus disease 2019 (COVID-19) may be directly associated with more …

Traditional Chinese Medicine, Qingfei Paidu Decoction and Xuanfei Baidu Decoction, Inhibited Cytokine Production via NF-κB Signaling Pathway in Macrophages …

Y Li, B Li, P Wang, Q Wang - Frontiers in Pharmacology, 2021 - frontiersin.org
Background and Aims: Qingfei Paidu decoction (QPD) and Xuanfei Baidu decoction (XBD)
are two typical traditional Chinese medicines with proven efficacy for the treatment of SARS …

Polymer-based nano-therapies to combat COVID-19 related respiratory injury: progress, prospects, and challenges

MM Rana - Journal of Biomaterials Science, Polymer Edition, 2021 - Taylor & Francis
The recent coronavirus disease-2019 (COVID-19) outbreak has increased at an alarming
rate, representing a substantial cause of mortality worldwide. Respiratory injuries are major …

Pathogenesis and treatment of cytokine storm in COVID-19

M Soy, G Keser, MP Atagündüz - Turkish Journal of Biology, 2021 - journals.tubitak.gov.tr
COVID-19 is a viral infection caused by the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) that killed a large number of patients around the world. A hyperinflammatory …

Targeting autophagy regulation in NLRP3 inflammasome-mediated lung inflammation in COVID-19

YY Yong, L Zhang, YJ Hu, JM Wu, L Yan, YR Pan… - Clinical …, 2022 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Emerging evidence indicates that …

A broad antiviral strategy: inhibitors of human DHODH pave the way for host-targeting antivirals against emerging and re-emerging viruses

Y Zheng, S Li, K Song, J Ye, W Li, Y Zhong, Z Feng… - Viruses, 2022 - mdpi.com
New strategies to rapidly develop broad-spectrum antiviral therapies are urgently required
for emerging and re-emerging viruses. Host-targeting antivirals (HTAs) that target the …

Cardiovascular events and safety outcomes associated with remdesivir using a World Health Organization international pharmacovigilance database

SY Jung, MS Kim, H Li, KH Lee… - Clinical and …, 2022 - Wiley Online Library
Abstract On October 2020, the US Food and Drug Administration (FDA) approved remdesivir
as the first drug for the treatment of coronavirus disease 2019 (COVID‐19), increasing …

From the ketogenic diet to the Mediterranean diet: the potential dietary therapy in patients with obesity after CoVID-19 infection (Post CoVID syndrome)

L Barrea, C Vetrani, M Caprio, M Cataldi… - Current Obesity …, 2022 - Springer
Purpose of review This review primarily examines the evidence for areas of consensus and
on-going uncertainty or controversy about diet and physical exercise approaches for in the …

[HTML][HTML] Bacillus licheniformis reverses the environmental ceftriaxone sodium-induced gut microbial dysbiosis and intestinal inflammation in mice

Z Zeng, W Yue, C Kined, PP Wang, R Liu, J Liu… - Ecotoxicology and …, 2023 - Elsevier
Antibiotics used as a common clinical treatment have saved many lives. Widespread use of
antibiotic therapy has been known to disrupt the balance of pathogenic bacteria, host …

[HTML][HTML] In silico drug repurposing in COVID-19: A network-based analysis

P Sibilio, S Bini, G Fiscon, M Sponziello, F Conte… - Biomedicine & …, 2021 - Elsevier
The SARS-CoV-2 pandemic is a worldwide public health emergency. Despite the beginning
of a vaccination campaign, the search for new drugs to appropriately treat COVID-19 …